High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss
High-Dose Glucocorticoids for Sudden Hearing LossThis trial compared courses of high-dose intravenous prednisolone or high-dose oral dexamethasone versus standard-dose oral prednisone in adults with idiopathic sudden sensorineural hearing loss. At 30 days, systemic high-dose glucocorticoid therapy was not superior to a lower-dose regimen with respect to change in hearing threshold, and it was associated with a higher risk of side effects.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:3 |
|---|---|
| Enthalten in: |
NEJM evidence - 3(2024), 1 vom: 01. Jan., Seite EVIDoa2300172 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Plontke, Stefan K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7S5I7G3JQL |
|---|
| Anmerkungen: |
Date Completed 11.02.2024 Date Revised 11.02.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1056/EVIDoa2300172 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368098915 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368098915 | ||
| 003 | DE-627 | ||
| 005 | 20240211232016.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240207s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/EVIDoa2300172 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1288.xml |
| 035 | |a (DE-627)NLM368098915 | ||
| 035 | |a (NLM)38320514 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Plontke, Stefan K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a High-Dose Glucocorticoids for the Treatment of Sudden Hearing Loss |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.02.2024 | ||
| 500 | |a Date Revised 11.02.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a High-Dose Glucocorticoids for Sudden Hearing LossThis trial compared courses of high-dose intravenous prednisolone or high-dose oral dexamethasone versus standard-dose oral prednisone in adults with idiopathic sudden sensorineural hearing loss. At 30 days, systemic high-dose glucocorticoid therapy was not superior to a lower-dose regimen with respect to change in hearing threshold, and it was associated with a higher risk of side effects | ||
| 650 | 4 | |a Clinical Trial | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 650 | 7 | |a Glucocorticoids |2 NLM | |
| 650 | 7 | |a Prednisone |2 NLM | |
| 650 | 7 | |a VB0R961HZT |2 NLM | |
| 700 | 1 | |a Girndt, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Meisner, Christoph |e verfasserin |4 aut | |
| 700 | 1 | |a Fischer, Imma |e verfasserin |4 aut | |
| 700 | 1 | |a Böselt, Iris |e verfasserin |4 aut | |
| 700 | 1 | |a Löhler, Jan |e verfasserin |4 aut | |
| 700 | 1 | |a Ludwig-Kraus, Beatrice |e verfasserin |4 aut | |
| 700 | 1 | |a Richter, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Steighardt, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Reuter, Bernd |e verfasserin |4 aut | |
| 700 | 1 | |a Böttcher, Christoph |e verfasserin |4 aut | |
| 700 | 1 | |a Langer, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Pethe, Wolfram |e verfasserin |4 aut | |
| 700 | 1 | |a Seiwerth, Ingmar |e verfasserin |4 aut | |
| 700 | 1 | |a Jovanovic, Nebojsa |e verfasserin |4 aut | |
| 700 | 1 | |a Großmann, Wilma |e verfasserin |4 aut | |
| 700 | 1 | |a Kienle-Gogolok, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Boehm, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Neudert, Marcus |e verfasserin |4 aut | |
| 700 | 1 | |a Diensthuber, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Müller, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Dazert, Stefan |e verfasserin |4 aut | |
| 700 | 1 | |a Guntinas-Lichius, Orlando |e verfasserin |4 aut | |
| 700 | 1 | |a Hornung, Joachim |e verfasserin |4 aut | |
| 700 | 1 | |a Vielsmeier, Veronika |e verfasserin |4 aut | |
| 700 | 1 | |a Stadler, Joachim |e verfasserin |4 aut | |
| 700 | 1 | |a Rahne, Torsten |e verfasserin |4 aut | |
| 700 | 0 | |a HODOKORT Trial Investigators |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t NEJM evidence |d 2022 |g 3(2024), 1 vom: 01. Jan., Seite EVIDoa2300172 |w (DE-627)NLM339641495 |x 2766-5526 |7 nnns |
| 773 | 1 | 8 | |g volume:3 |g year:2024 |g number:1 |g day:01 |g month:01 |g pages:EVIDoa2300172 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/EVIDoa2300172 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 3 |j 2024 |e 1 |b 01 |c 01 |h EVIDoa2300172 | ||